Jiangsu Hengrui Medicine
600276.SS
#469
Rank
โ‚ฌ41.05 B
Marketcap
6,44ย โ‚ฌ
Share price
-1.00%
Change (1 day)
3.85%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of September 2024 : โ‚ฌ5.90 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has โ‚ฌ5.90 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$โ‚ฌ5.19 B5.34%
2021-12-31$โ‚ฌ4.92 B28.44%
2020-12-31$โ‚ฌ3.83 B20.43%
2019-12-31$โ‚ฌ3.18 B25.82%
2018-12-31$โ‚ฌ2.53 B24%
2017-12-31$โ‚ฌ2.04 B15.87%
2016-12-31$โ‚ฌ1.76 B20.6%
2015-12-31$โ‚ฌ1.46 B34.99%
2014-12-31$โ‚ฌ1.08 B35.96%
2013-12-31$โ‚ฌ0.79 B20.68%
2012-12-31$โ‚ฌ0.65 B23.02%
2011-12-31$โ‚ฌ0.53 B35.78%
2010-12-31$โ‚ฌ0.39 B45.07%
2009-12-31$โ‚ฌ0.27 B28.13%
2008-12-31$โ‚ฌ0.21 B36.75%
2007-12-31$โ‚ฌ0.15 B26.31%
2006-12-31$โ‚ฌ0.12 B6.13%
2005-12-31$โ‚ฌ0.11 B30.26%
2004-12-31$โ‚ฌ89 M2.55%
2003-12-31$โ‚ฌ86.79 M-7.28%
2002-12-31$โ‚ฌ93.61 M-9.73%
2001-12-31$โ‚ฌ0.10 B